UK Genomics Spotlight 2024: Celebrating success and looking ahead
The UK has world-leading capabilities in genomics, from the NHS Genomic Medicine Service which is the first national healthcare system in the world to offer Whole Genome Sequencing (WGS) as part of routine care, to world-leading institutions and research cohorts, to the ever-expanding innovation of UK small businesses.
The Department for Business and Trade (DBT) has produced the Genomics Spotlight 2024 to showcase the UK’s expertise in genomics and the latest developments that make the UK a hub for genomics business and investment. DBT has worked closely with the NHS, including NHS England and all 3 of the devolved nations, as well as encouraging input from several key organisations and companies in the UK.
The document highlights both the export potential of UK companies, as well as the investment potential across the wider NHS infrastructure and research institutes.
This document, while not comprehensive, showcases UK capabilities in genomics, with the aim to promote this sector to markets around the world, to promote UK plc and the healthcare institutions in place.
